In contrast, the levels of IL-18 and chemerin, although elevated in subjects with all metabolic abnormalities, only showed statistically significant increases in participants with specific abnormalities, namely high blood pressure, high triglycerides, and low HDL cholesterol (q < 0.05; Figure 2a–c). This evidence concerns the gene IL18 and hypertensive disorder.